Clinical Trial Update: Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial compares the anti-inflammatory effects of rivaroxaban versus dabigatran in patients with atrial fibrillation. The current status and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Pradaxa (dabigatran etexilate)
• Xarelto (rivaroxaban)

Snippet

Sponsor: Yokohama City University Medical Center | Conditions: Atrial Fibrillation | Phase 4 | Status: UNKNOWN